Physician profile
Weiping Yao
NPI 1861460735
$25,708.82
in general payments reported to CMS, 2019-2025
78 companies · $4,666 in 2025
The $4,666 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,117 · 2020: $2,264 · 2021: $2,921 · 2022: $4,923 · 2023: $3,207 · 2024: $4,611 · 2025: $4,666.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Education: $15.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,467.63 |
| Education | $15.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,535.09 | 2021-2025 | Ubrelvy, Botox, Qulipta |
| Ucb, INC. | $2,268.13 | 2019-2025 | Fintepla, Zilbrysq, Briviact |
| Biogen, INC. | $1,648.40 | 2019-2025 | Vumerity, Tysabri, Leqembi |
| Lilly USA, LLC | $1,104.60 | 2019-2025 | Amyvid, Kisunla, Emgality |
| Sk Life Science, INC. | $1,101.24 | 2020-2025 | Xcopri |
| Amneal Pharmaceuticals LLC | $1,087.18 | 2019-2025 | Rytary, Crexont, Ongentys |
| Mdd US Operations, LLC | $1,045.94 | 2019-2025 | Gocovri, Qelbree, Gocovri |
| Genzyme Corporation | $749.91 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $719.12 | 2019-2025 | Ultomiris, Strensiq, Soliris |
| Eisai INC. | $699.68 | 2020-2025 | |
| Acadia Pharmaceuticals INC | $697.59 | 2019-2025 | Nuplazid |
| Novartis Pharmaceuticals Corporation | $693.48 | 2019-2025 | |
| Amgen INC. | $688.00 | 2019-2025 | Uplizna, Tepezza |
| Emd Serono, INC. | $630.08 | 2019-2025 | Mavenclad, Mavenclad |
| Pfizer INC. | $603.36 | 2022-2025 |
Show all 78 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $532.47 | 2019-2025 | Austedo Xr, Austedo Xr |
| Allergan, INC. | $479.92 | 2019-2022 | |
| Livanova USA, INC. | $450.05 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Neurelis, INC. | $422.73 | 2020-2025 | Valtoco |
| Merz Pharmaceuticals, LLC | $389.34 | 2022-2025 | Xeomin, Inbrija |
| Neurocrine Biosciences, INC. | $388.63 | 2021-2025 | Ingrezza |
| Otsuka America Pharmaceutical, INC. | $371.07 | 2023-2025 | Rexulti, Nuedexta |
| Lundbeck LLC | $358.81 | 2019-2025 | Rexulti |
| Biohaven Pharmaceutical Holding Company LTD. | $357.09 | 2022 | |
| Genentech USA, INC. | $351.63 | 2019-2025 | Ocrevus, Enspryng, Ocrevus Zunovo |
| Argenx US, INC. | $332.28 | 2022-2025 | Vyvgart Hytrulo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $322.60 | 2019-2024 | Jardiance |
| Sanofi-Aventis U.S. LLC | $319.98 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $309.58 | 2019-2022 | |
| Acorda Therapeutics, INC | $259.26 | 2019-2023 | Ampyra, Inbrija |
| Jazz Pharmaceuticals INC. | $258.74 | 2023-2025 | Epidiolex |
| Janssen Pharmaceuticals, INC | $257.72 | 2019-2025 | Spravato |
| Celgene Corporation | $248.18 | 2021-2024 | Zeposia |
| Silk Road Medical, INC. | $213.64 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $188.51 | 2023-2025 | Hyqvia |
| Adamas Pharmaceuticals, INC. | $188.32 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $183.65 | 2020-2021 | |
| Avanir Pharmaceuticals, INC. | $177.50 | 2019-2022 | |
| Impel Pharmaceuticals INC. | $170.82 | 2022 | |
| Ge Healthcare | $161.44 | 2022-2025 | |
| Horizon Therapeutics Plc | $135.70 | 2022-2023 | Uplizna |
| Catalyst Pharmaceuticals, INC. | $121.13 | 2022-2023 | Fycompa, Firdapse |
| Kyowa Kirin, INC. | $106.65 | 2022-2024 | Nourianz, Crysvita |
| Grifols USA, LLC | $102.99 | 2022-2023 | Gamunex-C |
| Aucta Pharmaceuticals, INC. | $94.44 | 2024 | Motpoly Xr |
| Banner Life Sciences, LLC | $86.33 | 2022-2024 | |
| Vanda Pharmaceuticals INC. | $79.44 | 2024-2025 | Fanapt, Hetlioz, Ponvory |
| Janssen Biotech, INC. | $77.64 | 2025 | |
| Mannkind Corporation | $71.11 | 2019 | |
| Kedrion Biopharma, INC. | $69.16 | 2025 | Rhogam Ultra-Filtered Plus, Albuked, Kedrab |
| Medtronic, INC. | $68.41 | 2022-2024 | Minimed 780g |
| Csl Behring | $58.72 | 2023 | Hizentra |
| Becton, Dickinson and Company | $57.71 | 2021-2022 | |
| Corcept Therapeutics | $54.35 | 2025 | Korlym |
| Abbott Laboratories | $45.94 | 2021-2024 | Infinity |
| Octapharma USA, INC. | $40.39 | 2023-2024 | Panzyga |
| Sumitomo Pharma America, INC. | $36.60 | 2023 | Aptiom |
| Novo Nordisk INC | $34.10 | 2019-2022 | |
| Tg Therapeutics, INC. | $34.05 | 2025 | |
| Idorsia Pharmaceuticals US INC | $30.78 | 2023 | Quviviq |
| Greenwich Biosciences, INC. | $29.05 | 2019 | |
| Akcea Therapeutics, INC. | $24.76 | 2019 | |
| Ani Pharmaceuticals, INC. | $24.71 | 2025 | Purified Cortrophin Gel |
| Tanabe Pharma America, INC. | $23.93 | 2024 | |
| Biotissue Holdings INC. | $22.97 | 2022 | |
| Cala Health, INC. | $21.21 | 2023 | Cala Trio, Cala Kiq |
| Neuropace, INC. | $18.54 | 2024 | |
| Cequr Corporation | $18.21 | 2023 | Cequr Simplicity |
| Axsome Therapeutics, INC. | $17.58 | 2025 | Symbravo |
| E.R. Squibb & Sons, L.L.C. | $16.70 | 2021 | |
| Rgh Enterprises LLC | $16.38 | 2025 | |
| Dexcom, INC. | $16.33 | 2021 | |
| Merz North America, INC. | $15.80 | 2019 | |
| Impel Pharmaceuticals LLC | $15.74 | 2024 | Trudhesa |
| Xeris Pharmaceuticals, INC. | $15.64 | 2022 | |
| Scilex Pharmaceuticals INC. | $14.04 | 2024 | |
| Averitas Pharma INC. | $13.38 | 2023 | Qutenza |
| Shire North American Group INC | $12.45 | 2019 |
Drugs and devices associated with these payments
Qulipta $816Ubrelvy $804Gocovri $699Fintepla $638Vumerity $539Rexulti $537Nurtec Odt $507Tysabri $478Leqembi $476Zavzpret $454Rytary $365Ultomiris $352Botox $339Valtoco $313Ingrezza $305Zilbrysq $300Vns Therapy Sentiva Model 1000 Generator $277Epidiolex $259Briviact $252Vyvgart Hytrulo $249Uplizna $242Mavenclad $222Zeposia $217Inbrija $186Xeomin $175Kesimpta $158Jardiance $158Hyqvia $158Nayzilam $154Paxlovid $134Amyvid $130Kisunla $121Ocrevus $109Strensiq $102Rystiggo $98.91Soliris $98.28Emgality $95.34Nuplazid $95.23Panzyga $95.06Motpoly Xr $94.44Qelbree $89.67Comirnaty $82.53Duopa $74.65Enspryng $71.68Gamunex-C $69.31Kedrab $69.16Gammaked $69.16Albuked $69.16Rhogam Ultra-Filtered Plus $69.16Koate $69.16Fanapt $63.00Hetlioz $63.00Fycompa $61.46Crexont $60.07Hizentra $58.72Austedo Xr $56.87Korlym $54.35Aubagio $49.10Nourianz $48.72Zepbound $46.68Tepezza $46.57Firdapse $43.31Vraylar $40.43Aptiom $36.60Xcopri $34.86Vyalev $34.50Briumvi $34.05Bafiertam $31.56Quviviq $30.78Ocrevus Zunovo $25.45Spravato $25.42Purified Cortrophin Gel $24.71Radicava $23.93Radicava Ors $23.93Mounjaro $22.26Crysvita $22.24Infinity $22.01Minimed 780g $21.78Skyclarys $21.40Cala Kiq $21.21Cala Trio $21.21Ampyra $21.19Reyvow $20.70Plegridy $19.91Avonex $19.91Rns Neurostimulator Kit $18.54Cequr Simplicity $18.21Symbravo $17.58Mayzent $17.19Ponvory $16.44Trudhesa $15.74Nuedexta $15.51Ztlido $14.04Ongentys $13.50Qutenza $13.38
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Weiping Yao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.